Telcare Receives CE Mark for Wireless Blood Glucose Meter

Telcare (Bethesda, MD) received CE Mark approval from the European Union for its wireless blood glucose meter, dubbed mHealth. This CE Mark represents the first entry of a wireless blood glucose meter into the European market.As of now, an estimated 360 million people around the world are diabetic. By 2030, this number is expected to rise to 552 million. While diabetes can be prevented through careful monitoring and proper diet, an estimated 8,700 people still die from this disease every year. With Telcare's wireless blood glucose monitor, patients can quickly and easily share information about blood sugar levels with a physician. Based on this information, physicians can make personalized treatment choices for patients."We are excited to expand our reach of innovative, comprehensive diabetes management solutions to the European Union," stated Dr. Jonathan Javitt, CEO and co-founder of Telcare. "Our mobile platform unlocks the power of clinical data and creates multiple engagement points amongst those involved in an individual's care to help minimize complications and improve health outcomes."More news about diabetes treatment technologiesAbbott Recalls FreeStyle InsuLinx Blood Glucose MeterWork on Artificial Pancreas ProgressingTandem Diabetes Receives FDA Clearance for t:connect Software